Key facts
- Navina’s last known valuation is $290.0M (Mar 2025).
- It has raised $99.0M; the latest was Later Stage VC ($55.0M) in Mar 2025.
- Notable investors include Goldman Sachs Growth Equity, Vertex Ventures Israel, Schusterman Family Investments, ALIVE Israel Healthtech Fund, ELQ Investors VIII — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Navina
- ·The full record, as it builds
Funding rounds
No funding rounds for Navina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Navina
Developer of a healthcare platform designed to transform the way clinicians interact with patient data to enhance care delivery. The company's platform aggregates data from multiple sources applies machine learning to identify conditions and care gaps, offers transparent explanations linked to original records, and integrates seamlessly into existing workflows, enabling healthcare providers to streamline administration, improve diagnostic accuracy, enhance risk assessment, and optimize patient care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 177
- Website
- navina.ai/
- Ownership
- Privately Held (backing)
Navina doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Navina shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Navina in its N-PORT filings yet. We sweep new filings monthly.